Lysogene announces that, following a decision by the court-appointed administrator, the deadline for submitting takeover bids has been extended from March 15 to April 12 at 12:00. Lysogene's shares will therefore remain suspended from trading.

As a reminder, the search for a buyer is part of the receivership procedure which the biopharmaceutical company is undergoing, and which was opened by decision of the Nanterre Commercial Court on January 24.

Copyright (c) 2023 CercleFinance.com. All rights reserved.